ARRY 142886,
ARRY-142886,
ARRY142886,
AZD 6244,
AZD-6244,
AZD6244,
selumetinib,
Selumetinib,
606143-52-6,
AZD6244,
AZD 6244,
ARRY-142886,
AZD-6244,
5-[(4-BROMO-2-CHLOROPHENYL)AMINO]-4-FLUORO-N-(2-HYDROXYETHOXY)-1-METHYL-1H-BENZIMIDAZOLE-6-CARBOXAMIDE,
ARRY 142886,
AZD6244 (Selumetinib),
ARRY-886,
Selumetinib (AZD6244),
UNII-6UH91I579U,
AZD6244(Selumetinib),
5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide,
5-(4-broMo-2-chlorophenylaMino)-4-fluoro-N-(2-hydroxyethoxy)-1-Methyl-1H-benzo[d]iMidazole-6-carboxaMide,
CHEMBL1614701,
CHEBI:90227,
6UH91I579U,
NCGC00189073-01,
NCGC00189073-02,
AK-40782,
C17H15BrClFN4O3,
DSSTox_CID_28870,
DSSTox_RID_83139,
DSSTox_GSID_48944,
1H-Benzimidazole-6-carboxamide, 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-,
Q-101405,
AZD 6244;5-((4-Bromo-2-chlorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide,
CAS-606143-52-6,
ARRY142886,
Selumetinib [USAN:INN],
selumetinibum,
1H-Benzimidazole-6-carboxamide, 5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-,
PubChem21092,
AZD 6244 Selumetinib,
Selumetinib (USAN/INN),
AZD-6244(Selumetinib),
AZD6244 - Selumetinib,
AZD 6244 (Selumetinib),
JSPY-st000254,
SCHEMBL155456,
GTPL5665,
QCR-91,
Selumetinib, ARRY-142886,
DTXSID3048944,
CTK8B4577,
EX-A020,
SYN1016,
CYOHGALHFOKKQC-UHFFFAOYSA-N,
BCPP000367,
CC-49,
HMS3244G03,
HMS3244G04,
HMS3244H03,
HMS3265K01,
HMS3265K02,
HMS3265L01,
HMS3265L02,
HMS3654O03,
NSC 741O78,
AOB87732,
API01002,
BCP01739,
Tox21_113362,
ABP000918,
ANW-45526,
BDBM50355497,
MFCD11977472,
NSC741078,
RS0061,
s1008,
ZINC31773258,
ARRY142886/AZD6244,
AKOS015904255,
Tox21_113362_1,
ACN-031539,
AN-4474,
BCP9000354,
CS-0059,
DB11689,
EX-8621,
NSC-741078,
SB14707,
KS-0000003K,
NCGC00189073-07,
4CA-0236,
AC-25059,
AJ-84328,
AM808016,
AZD6244,Selumetinib, ARRY-142886,
BC004624,
BC660025,
CJ-17817,
HY-50706,
SC-85661,
AZD6244 (Selumetinib ARRY-142886),
AZD6244 (Selumetinib, ARRY142886),
AB0007973,
AX8165426,
TX-013341,
FT-0674552,
ST24031611,
SW202561-3,
X2640,
D09666,
S-7764,
143A526,
BRD-K57080016-001-01-9,
I14-17010,
3EW,
5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzodiazole-6-carboxamide,
5-[(4-Bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxami,
6-(4-bromo-2-chloro-anilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-benzimidazole-5-carboxamide,
6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy -ethoxy)-amide,
6-(4-Bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide,
6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid(2-hydroxy-ethoxy)-amide,
6-(4-bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide,
6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide,
6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid(2-hydroxyethoxy)-amide,
6-(4-bromo-2-chlorophenylamino)-N-(2-hydroxyethoxy)-3,7-dimethyl-3H-benzo[d]imidazole-5-carboxamide,
6-(4-bromo-2chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide,
MEK inhibitors,
D0T5DP,
D0TH0Z,
CID10127622,
A8207,
A8446,
A10257,
C517975,
Selumetinib, 99%, a highly selective MEK1 inhibitor - 1G 1g,
ARRY-142886, Selumetinib, AZD-6244, ARRY142886, AZD6244,
6-(4-bromo-2-chlorophenylamino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-3H-benzo[d]imidazole-5-carboxamide,